ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 130 filers reported holding ASCENDIS PHARMA A/S in Q3 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $537,000 | -4.8% | 5,576 | +13.9% | 0.01% | -7.1% |
| Q2 2019 | $564,000 | +4.4% | 4,896 | +6.7% | 0.01% | 0.0% |
| Q1 2019 | $540,000 | +35.0% | 4,590 | -28.2% | 0.01% | +27.3% |
| Q4 2018 | $400,000 | -49.0% | 6,392 | -42.3% | 0.01% | -42.1% |
| Q3 2018 | $785,000 | +9.8% | 11,084 | +3.2% | 0.02% | +5.6% |
| Q2 2018 | $715,000 | +14.0% | 10,744 | +12.1% | 0.02% | +5.9% |
| Q1 2018 | $627,000 | – | 9,588 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,225,357 | $1,001,863,112 | 18.92% |
| Q Global Advisors, LLC | 195,000 | $17,404 | 12.55% |
| Sofinnova Investments, Inc. | 754,032 | $67,297,356 | 4.41% |
| Avoro Capital Advisors LLC | 3,580,555 | $319,564,534 | 4.34% |
| Finepoint Capital LP | 139,772 | $12,474,651 | 4.32% |
| Spyglass Capital Management LLC | 657,853 | $58,713,380 | 4.24% |
| Saturn V Capital Management LP | 78,442 | $7,000,948 | 3.88% |
| DAFNA Capital Management LLC | 135,212 | $12,067,671 | 3.30% |
| ARS Investment Partners, LLC | 289,860 | $25,870,005 | 3.02% |
| Ghost Tree Capital, LLC | 100,000 | $8,925,000 | 2.95% |